Aurealis Therapeutics successfully completes treatment period of its Phase 1 study for AUP-16 in non-healing DFUs.
Contact
Hochbergerstrasse 60CCH-4057 Basel Switzerland
Microkatu 1FI-70210 Kuopio Finland